0000899243-21-016935.txt : 20210423
0000899243-21-016935.hdr.sgml : 20210423
20210423200013
ACCESSION NUMBER: 0000899243-21-016935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210319
FILED AS OF DATE: 20210423
DATE AS OF CHANGE: 20210423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Falconer Ester
CENTRAL INDEX KEY: 0001844479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 21851131
MAIL ADDRESS:
STREET 1: C/O ABCELLERA BIOLOGICS INC.
STREET 2: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-19
0
0001703057
AbCellera Biologics Inc.
ABCL
0001844479
Falconer Ester
C/O ABCELLERA BIOLOGICS INC.
2215 YUKON STREET
VANCOUVER
A1
V5Y 0A1
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Technology Officer
Common Shares
2021-03-19
4
M
0
1000000
0.0343
A
1000000
D
Share Option (right to buy)
0.0343
2021-03-19
4
M
0
1000000
0.00
D
2025-08-04
Common Shares
1000000
0
D
The exercise price reported above was converted from the Canadian exercise price of CAD $0.0450 using an exchange rate on August 4, 2015 of CAD $1.313 = US $1.00.
As of the date of the transaction, the option was fully vested and exercisable.
/s/ Tryn Stimart, attorney-in-fact
2021-04-23